Showing results (11-20 of 163) with videos related to
Sort By:
Pageof 17
Seminars in Hematology|September 30, 2010
Resistance to imatinib: mutations and beyondPaul La Rosée, Michael W DeiningerGenome Biology|October 16, 2014
Individualizing kinase-targeted cancer therapy: the paradigm of chronic myeloid leukemiaAnna M Eiring, Michael W DeiningerBlood|December 27, 2024
Novel treatment strategies for chronic myeloid leukemiaNataly Cruz-Rodriguez, Michael W DeiningerBlood Reviews|March 28, 2021
Chronic Myeloid Leukemia: Modern therapies, current challenges and future directionsAfaf E G Osman, Michael W DeiningerHematology/Oncology Clinics of North America|July 5, 2017
Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase InhibitorsAmi B Patel, Thomas O'Hare, Michael W DeiningerThe Plant Cell|August 17, 1999
Volvoxrhodopsin, a light-regulated sensory photoreceptor of the spheroidal green alga Volvox carteriE Ebnet, M Fischer, W Deininger, et al.Expert Opinion on Investigational Drugs|May 22, 2008
New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in checkThomas O'Hare, Christopher A Eide, Michael W DeiningerClinical Pharmacology : Advances and Applications|August 3, 2019
Novel approaches to treating advanced systemic mastocytosisJ A Gilreath, L Tchertanov, M W DeiningerClinical Lymphoma & Myeloma|March 27, 2007
Bcr-Abl kinase domain mutations and the unsettled problem of Bcr-AblT315I: looking into the future of controlling drug resistance in chronic myeloid leukemiaThomas O'Hare, Christopher A Eide, Michael W DeiningerCancer Journal (Sudbury, Mass.)|December 14, 2011
Development of an effective therapy for chronic myelogenous leukemiaDavid W Woessner, Carol S Lim, Michael W DeiningerPageof 17